Article Details
Retrieved on: 2024-04-23 18:27:52
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the challenges and future of monoclonal antibody therapies for infectious diseases like COVID-19 and HIV, exploring new business models required for global accessibility and advancements influenced by past experiences and current biotechnological capabilities in Siena's Biotecnopolo di Siena Foundation.
Article found on: www.iavi.org
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here